(Q35967453)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15571503%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

review article

1 reference

title

Therapy of systemic fungal infections (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15571503%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15571503%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

Katie R Pang

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15571503%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

David B Huang

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15571503%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Stephen K Tyring

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15571503%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

publication date

1 January 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15571503%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15571503%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15571503%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15571503%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

page(s)

532-538

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15571503%20AND%20SRC:MED&resulttype=core&format=json

Lipid formulations of amphotericin B: recent progress and future directions

5 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1396-0296.2004.04057.X

A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1396-0296.2004.04057.X

Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1396-0296.2004.04057.X

Limited toxicity of prolonged therapy with high doses of amphotericin B lipid complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1396-0296.2004.04057.X

Liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1396-0296.2004.04057.X

High-dose itraconazole in the treatment of severe mycoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1396-0296.2004.04057.X

Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy. A randomized, controlle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1396-0296.2004.04057.X

Voriconazole: a new triazole antifungal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1396-0296.2004.04057.X

Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1396-0296.2004.04057.X

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1396-0296.2004.04057.X

Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1396-0296.2004.04057.X

Fluconazole combined with flucytosine for treatment of cryptococcal meningitis in patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1396-0296.2004.04057.X

Clinical efficacy of echinocandin antifungals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1396-0296.2004.04057.X

In vitro activity of caspofungin (MK-0991) against Candida albicans clinical isolates displaying different mechanisms of azole resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1396-0296.2004.04057.X

Echinocandins and pneumocandins--a new antifungal class with a novel mode of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1396-0296.2004.04057.X

A randomized double-blind study of caspofungin versus amphotericin for the treatment of candidal esophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1396-0296.2004.04057.X

Randomized, double-blind, multicenter study of caspofungin versus amphotericin B for treatment of oropharyngeal and esophageal candidiases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1396-0296.2004.04057.X

Investigational antifungal agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1396-0296.2004.04057.X

Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance P

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1396-0296.2004.04057.X

In vitro antifungal susceptibilities of Trichosporon species.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1396-0296.2004.04057.X

In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole against 37 clinical isolates of zygomycetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1396-0296.2004.04057.X

10.1111/J.1396-0296.2004.04057.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15571503%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference